CL vs CLYM · P/E 34, rev $10.69B vs $85.8M cap
Colgate-Palmolive Company (CL) versus Climb Bio Inc (CLYM) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CLYM does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CLYM currently screens at market cap $85.8M.
Not investment advice. Open the CL and CLYM stock pages for the full models.
Not investment advice.